monthly glp 1 📣 Big news for Medicare and GLP1s! Starting July 2026, CMS is making GLP-1 medications more affordable with $50 access. Expanding access to innovative treatments! Who else is as excited as Companies developing monthly GLP-1 medication

It means the evidence exists in a form the current approval infrastructure was not built to process

de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD

Using such a product doesn't just skew your results

For degradation of fatty acids with shorter chain length mitochondria have different enzymes which are outside the scope of this review but are described elsewhere [11]

A build-up of these cells can contribute to inflammation and tissue dysfunction

To ask whether other -KG-producing enzymes regulate the YBX1AMPK axis similarly to GDH1, we further knocked down GPT2 and/or GOT2 in Huh7 and H1299 cells and found that GPT2 and GOT2 single or double depletion minimally impacted YBX1 and AMPK expression and intracellular -KG abundance (Supplementary Fig